Center Book Partners LP Catalyst Pharmaceuticals, Inc. Transaction History

Center Book Partners LP

  • $1.54 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$11.69 - $15.02 $26,407 - $33,930
2,259 Added 19.96%
13,577 $158,000
Q2 2023

Aug 14, 2023
BUY
$11.5 - $18.08 $130,157 - $204,629
11,318 New
11,318 $152,000
Q3 2022

Nov 14, 2022
BUY
$7.06 - $15.52 $185,190 - $407,105
26,231 New
26,231 $337,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email